StrVCTVRE
StrVCTVRE predicts the pathogenicity of structural variants (SVs), specifically deletions and duplications overlapping exons larger than 50 base pairs, to prioritize likely disease-causing variants.
Key Features:
- Pathogenicity Prediction: Predicts whether exon-overlapping deletions and duplications are pathogenic or benign.
- Random Forest Classifier: Uses a random forest classifier that integrates gene importance, coding-region characteristics, conservation levels, expression data, and exon structure.
- Feature Integration: Incorporates expression and conservation alongside gene and exon features, which are absent from current SV classification guidelines.
- Training Set Construction: Builds a size-matched training set of rare, putatively benign and pathogenic SVs compiled from multiple resources.
- Performance Metrics: Shows high accuracy across a wide range of SV sizes on independent test sets, reducing the number of SVs requiring further consideration by about half while maintaining 90% sensitivity.
Scientific Applications:
- Clinical Prioritization: Prioritizes SVs in probands lacking an immediately compelling single variant to aid case resolution.
- Long-read Sequencing Diagnostics: Assesses exon-overlapping SV pathogenicity to maximize diagnostic yield from long-read sequencing.
Methodology:
Implements a random forest classifier that integrates gene importance, coding-region features, conservation, expression, and exon structure; trains on a size-matched set of rare putatively benign and pathogenic SVs compiled from multiple resources; evaluates performance on independent test sets.
Topics
Collections
Details
- License:
- MIT
- Maturity:
- Mature
- Cost:
- Free of charge
- Tool Type:
- command-line tool, web application
- Operating Systems:
- Linux
- Programming Languages:
- Python
- Added:
- 4/12/2022
- Last Updated:
- 11/24/2024
Operations
Publications
Sharo AG, Hu Z, Sunyaev SR, Brenner SE. StrVCTVRE: A supervised learning method to predict the pathogenicity of human genome structural variants. The American Journal of Human Genetics. 2022;109(2):195-209. doi:10.1016/j.ajhg.2021.12.007. PMID:35032432. PMCID:PMC8874149.
Documentation
Downloads
- Source codehttps://github.com/andrewSharo/StrVCTVRE